Abstract
Background: Variants of SARS-CoV-2 have been detected along with the worldwide COVID-19 transmission. Insufficient data exists regarding SARS-CoV-2 variants in Iraq, particularly concerning travelers at Iraqi border crossings. This study aimed to screen SARS-CoV-2 variants among individuals entering Iraq from Turkey through the Ibrahim Khalil international border checkpoint.
Methods: A total of 116 (52 females, 64 males) COVID-19-positive cases from June 6, 2021, to July 30, 2021, were randomly selected from the Ibrahim Al-Khalil border crossing point between Turkey and Iraq. The patients were Iraqis tested positive for COVID-19 through nasopharyngeal and oropharyngeal swab collections. The confirmation of SARS-CoV-2 cases involved RNA extraction and real-time reverse transcription polymerase chain reaction (RT-PCR), following the World Health Organization guidelines. All samples were subjected to variant detection using the reverse transcription RT-PCR method. The RNA was extracted using a Zybio nucleic acid extraction kit and the RT-PCR was conducted using SARS-CoV-2 S-gene mutation detection RT-PCR kit.
Results: In the 116 patients, we detected variants B.1.1.7, B.1.617.1.2, B.1.617.1.3, and Omicron sub-lineages (B.1.1.529, BA.1) at frequency rates of 13, 16, 45, and 36 cases, respectively. The highest prevalence rate was the delta variant among the tested subjects (38.8%) followed by the Omicron sub-lineages (B.1.1.529, BA.1) at 31%.
Conclusion: This finding, which is the first of its kind at the northern Iraqi border checkpoint, suggests that these two variants could be a source of COVID-19 circulating in the Duhok province in Iraq. Additional studies are warranted across the country’s border entry points.
Downloads
References
- Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, et al. Insights for COVID-19 in 2023. Rev Esp Quimioter. 2023;36(2):114-124. doi: 10.37201/req/122.2022.
- Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev Med Virol. 2022;32(4): e2313. doi: 10.1002/rmv.2313.
- Long B, Carius BM, Chavez S, et al. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. Am J Emerg Med. 2022; 54:46-57. doi: 10.1016/j.ajem.2022.01.028.
- Vasireddy D, Vanaparthy R, Mohan G, et al. Review of COVID-19 variants and COVID-19 vaccine efficacy: what the clinician should know? J Clin Med Res. 2021;13(6):317-325. doi: 10.14740/jocmr4518.
- Ramesh S, Govindarajulu M, Parise RS, et al. Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy. Vaccines (Basel). 2021;9(10):1195. doi: 10.3390/vaccines9101195.
- Merza MA, Almufty HB. The Omicron variant is striking Iraqi Kurdistan in January 2022: would preventive measures contain the new wave? Disaster Med Public Health Prep. 2022;9: 1-2. doi: 10.1017/dmp.2022.156.
- Merza MA, Haleem Al Mezori AA, Mohammed HM, et al. COVID-19 outbreak in Iraqi Kurdistan: the first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease. Diabetes Metab Syndr. 2020;14(4):547-554. doi: 10.1016/j.dsx.2020.04.047
- Al-Rashedi NAM, Alburkat H, Hadi AO, et al. High prevalence of an alpha variant lineage with a premature stop codon in ORF7a in Iraq, winter 2020-2021. PLoS One. 2022;17(5): e0267295. doi: 10.1371/journal.pone.0267295
- Sabir DK. Analysis of SARS-COV2 spike protein variants among Iraqi isolates. Gene Rep. 2022; 26:101420. doi: 10.1016/j.genrep.2021.101420.
- Grépin KA, Aston J, Burns J. Effectiveness of international border control measures during the COVID-19 pandemic: a narrative synthesis of published systematic reviews. Philos Trans A Math Phys Eng Sci. 2023;381(2257):20230134. doi: 10.1098/rsta.2023.0134.
- Salih DA, Ahmed JQ, Qader MK, et al. SARS-CoV-2 and RT-PCR testing in travelers: results of a cross-sectional study of travelers at Iraq's international borders. Disaster Med Public Health Prep. 2022;7: 1-3. doi: 10.1017/dmp.2022.140.
- Hussein NR, Rashad BH, Almizori LA, et al. The risk of SARS-CoV-2 reinfection in Duhok city, Kurdistan Region of Iraq. Mediterr J Hematol Infect Dis. 2021;13(1): e2021035. doi: 10.4084/MJHID.2021.035.
- World Health Organization Global surveillance for COVID-19 disease caused by human infection with the 2019 novel coronavirus. Interim guidance. 27 February 2020:2020.
- Singanayagam A, Patel M, Charlett A, et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. 2020;25(32):2001483. doi: 10.2807/1560-7917.ES.2020.25.32.2001483.
- Eskier D, Akalp E, Dalan Ö, et al. Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest. Turk J Biol. 2021 Feb 9;45(1):104-113. doi: 10.3906/biy-2008-56.
- Russell TW, Wu JT, Clifford S, et al. Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study. Lancet Public Health. 2021;6(1): e12-e20. doi: 10.1016/S2468-2667(20)30263-2.
- Merza MA, Abdulah DM, Malo DH, et al. Current status of COVID-19 infection and vaccination coverage, and factors associated with infection acquisition and vaccine uptake. Infect Dis Trop Med. 2023;9: e1062. doi: 10.32113/idtm_20231_1062.
